The slides for this webinar are available on our Slideshare account. Robin Markowitz and Elizabeth Lye from Lymphoma Canada discussed recent pCODR drug funding requests for innovative cancer therapies and how negative funding recommendations are affecting patient access to effective new treatments. The presentation was followed by an interactive question and answer session. Originally broadcast on
About the Webinar: The slides for this webinar are available on our Slideshare account. This webinar was an interactive live webcast from the Canadian Organization for Rare Disorders’ Rare Disease Day event in Ottawa. The session was moderated by 3Sixty Public Affairs’ Bill Dempster, who was joined by several Canadian experts in pharmaceutical access, including a
The slides for this webinar can be viewed at our Slideshare account. Speaker: Helene Hutchings, Founder/CEO of Anal Cancer: A Bum Rap, a Canadian based support group for past/present anal cancer patients and their families Broadcast Date: Thursday, March 8th CCSN welcomes back Helene Hutchings to discuss anal and colorectal cancer in this educational webinar. Helene discussed the
About the Webinar: The slides for this webinar can be viewed at our Slideshare account. Join Alexandra Chambers & oncologist Dr. Craig Earle with CADTH’s pan-Canadian Oncology Drug Review (pCODR) as they discuss the opportunities for clinicians to participate in the process and be part of the system, and how clinician input can help to inform
About the Webinar: The slides for this webinar can be viewed at our Slideshare account. Bill Dempster & guests Louise Binder & Martine Elias discussed the updates to the federal pharmaceutical price reform proposal, how patient leaders are responding and what steps they are taking to ensure that patients are being heard by decision makers. About the
For this webinar, we’re joined by Suzanne Lepage, private health plan specialist, for a discussion of Canada’s private drug plan marketplace and its overlap with government provided services. She’ll walk us through what to expect in terms of coverage and answer audience questions about private insurance.
Thursday, October 19 1:00pm – 2:00pm EST Biologic cancer treatments have become incredibly important in oncology, but they can be expensive. Biosimilars are molecules manufactured to replicate the effects of biologics. They give patients and providers a choice and help to drive prices down through competition, but doctors, patients and caregivers need to understand what
This webinar introduces you to the effects of blood clots on cancer patients. This webinar also provides you with the following information: How and why blood clots effect cancer patients more than the general population Diagnosis and treatment options Resources for more information The presentation is followed by an interactive discussion with participants. Presenter Information Dr.
This webinar introduces you to the Patented Medicine Prices Review Board (PMPRB), how they regulate drug pricing in Canada and the proposed changes that will affect cancer patients. This webinar also provides you with the following information: Summary, analysis and next steps regarding proposed price regulation changes Patient perspectives on the proposed reforms Discussion on potential